The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.
about
Insulin degludec and insulin aspart: novel insulins for the management of diabetes mellitusDistinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes MellitusUndeniable need for ultrafast-acting insulin: the pediatric perspectiveInsulin degludec/insulin aspart in Japanese patients with type 1 diabetes mellitus: Distinct prandial and basal glucose-lowering effects.Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study.The past, present, and future of basal insulins.Moving toward the ideal insulin for insulin pumps.Clinical use of the co-formulation of insulin degludec and insulin aspart.A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use.Insulin degludec/insulin aspart versus biphasic insulin aspart 30 twice daily in insulin-experienced Japanese subjects with uncontrolled type 2 diabetes: Subgroup analysis of a Pan-Asian, treat-to-target Phase 3 Trial.Investigation of the Physico-Chemical Properties that Enable Co-Formulation of Basal Insulin Degludec with Fast-Acting Insulin Aspart.Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1).Clinical considerations for use of insulin degludec/insulin aspart in Japanese patients.
P2860
Q26777076-EEA2C3CF-FD32-43A3-952A-58512CF81F92Q33785190-8E14EB3B-D540-4EEC-9D23-80F64A461AE3Q36229282-A817F981-F04E-47BB-A9EF-E419DA8D099BQ37060869-2D366474-91AB-499A-8530-601024EB9FE9Q37596013-83CD838C-FD5C-4E9B-BB73-72BBC6681B12Q38618376-2E3CBE01-22BD-4C4E-9C67-22B93C65EE05Q38631154-1BEF8714-AF6E-4E80-BD79-AF0988972DC8Q38887939-8E5113D1-8796-4ECE-BF61-28E4FB50B44FQ38970550-140ECA2E-0434-434C-A0D2-779CC839826CQ40810515-21199F82-14D3-47EA-AFFD-776A9C6610B0Q41558812-5581334A-5E80-4C49-A743-97D40DC2BAB2Q42329441-39F9F38F-741D-48BA-A4B3-5ED3680EDCAEQ48576692-DA9C4ED7-44C2-4CDE-A058-03643D67A5B5
P2860
The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.
@ast
The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.
@en
type
label
The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.
@ast
The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.
@en
prefLabel
The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.
@ast
The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.
@en
P2093
P2860
P356
P1433
P1476
The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.
@en
P2093
Jennifer L Sherr
Karena L Swan
Melody Martin
Stuart A Weinzimer
P2860
P304
P356
10.2337/DC11-0732
P407
P577
2012-02-28T00:00:00Z